Kauf Teresa L, Coates Thomas D, Huazhi Liu, Mody-Patel Nikita, Hartzema Abraham G
Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, Florida, USA.
Am J Hematol. 2009 Jun;84(6):323-7. doi: 10.1002/ajh.21408.
Although sickle cell disease (SCD) is marked by high utilization of medical resources, the full cost of care for patients with SCD, including care not directly related to SCD, is unknown. The purpose of this study was to estimate the total cost of medical care for a population of children and adults with SCD. We used data from individuals diagnosed with SCD enrolled in the Florida Medicaid program during 2001-2005 to estimate total, SCD-related, and non-SCD-related cost per patient-month based on patient age at the time of health care use. Across the 4,294 patient samples, total health care costs generally rose with age, from $892 to $2,562 per patient-month in the 0-9- and 50-64-year age groups, respectively. Average cost per patient-month was $1,389. Overall, 51.8% of care was directly related to SCD, the majority of which (80.5%) was associated with inpatient hospitalizations. Notably, non-SCD-related costs were substantially higher than those reported for the general US population. These results suggest a discounted (3% discount rate) lifetime cost of care averaging $460,151 per patient with SCD. Interventions designed to prevent SCD complications and avoid hospitalizations may reduce the significant economic burden of the disease.
尽管镰状细胞病(SCD)的特点是医疗资源利用率高,但SCD患者的全部护理成本,包括与SCD无直接关系的护理成本,仍不清楚。本研究的目的是估计患有SCD的儿童和成人人群的医疗护理总成本。我们使用了2001年至2005年期间参加佛罗里达州医疗补助计划的被诊断为SCD的个体的数据,根据医疗保健使用时的患者年龄来估计每位患者每月的总费用、与SCD相关的费用和与SCD无关的费用。在4294个患者样本中,总体医疗保健成本一般随年龄增长而上升,在0至9岁和50至64岁年龄组中,每位患者每月的费用分别从892美元升至2562美元。每位患者每月的平均费用为1389美元